ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Hot Features

Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

AQST Aquestive Therapeutics Inc

2,75
-0,06 (-2,14%)
Última atualização: 16:14:39
Atrasado em 15 minutos
Nome da Ação Código da Ação Bolsa de Valores Tipo de Ativo
Aquestive Therapeutics Inc AQST NASDAQ Ordinária
  Variação do Dia (p) Variação do Dia % Último Preço Hora
-0,06 -2,14% 2,75 16:14:39
Preço de Abertura Preço Mínimo Preço Máximo Fech. Hoje Fech. Anterior
2,85 2,72 2,885 2,81
mais cotações »

Notícias Recentes

Data Hora Fonte Título
03/06/202409:00GLOBEAquestive Therapeutics Announces Executive Appointments and..
28/05/202409:00GLOBEAquestive Therapeutics to Present Anaphylm™ (epinephrine)..
09/05/202409:00GLOBEAquestive Therapeutics to Participate in The Citizens JMP..
07/05/202417:19GLOBEAquestive Therapeutics Reports First Quarter 2024 Financial..
29/04/202408:00GLOBEAquestive Therapeutics Receives U.S. FDA Approval and Market..
25/04/202409:00GLOBEAquestive Therapeutics to Report First Quarter 2024..
12/04/202417:01GLOBEAquestive Therapeutics to Present Crossover Study Data for..
01/04/202409:00GLOBEAquestive Therapeutics Strengthens Board of Directors with..
25/03/202409:00GLOBEAquestive Therapeutics Announces Closing of Underwritten..
19/03/202422:49GLOBEAquestive Therapeutics Announces Pricing of $75 Million..
19/03/202417:01GLOBEAquestive Therapeutics Announces Proposed Public Offering of..
14/03/202418:23GLOBEAquestive Therapeutics Announces Pivotal Study for Anaphylm™..
05/03/202419:05GLOBEAquestive Therapeutics Reports Full Year 2023 Financial..
21/02/202410:00GLOBEAquestive Therapeutics to Report Fourth Quarter 2023..
15/02/202410:00GLOBEAquestive Therapeutics to Present Anaphylm™ (epinephrine)..
30/01/202410:00GLOBEAquestive Therapeutics to Participate in Oppenheimer 34th..
05/12/202310:00GLOBEAquestive Therapeutics Doses First Patient in Phase 3..
10/11/202310:00GLOBEAquestive Therapeutics to Present Positive Data from..
06/11/202318:37GLOBEAquestive Therapeutics Reports Third Quarter 2023 Financial..
02/11/202309:00GLOBEAquestive Therapeutics Completes $45 Million Debt..
31/10/202309:00GLOBEAquestive Therapeutics to Report Third Quarter 2023..
09/10/202309:00GLOBEAquestive Therapeutics Provides Business Update
20/09/202311:57DJNAquestive Therapeutics Shares Rise 12% on Anaphylm Trial..
20/09/202310:04GLOBEAquestive Therapeutics Reaffirms Timeline and Pathway for..
11/09/202309:00GLOBEAquestive Therapeutics Receives FDA Acceptance of New Drug..
23/08/202309:00GLOBEAquestive Therapeutics to Participate in Two Upcoming..
07/08/202317:01GLOBEAquestive Therapeutics Reports Second Quarter 2023 Financial..
02/08/202309:00GLOBEAquestive Therapeutics to Participate in 2023 Wedbush..
27/07/202308:00GLOBEAquestive Therapeutics Announces Positive Topline..
25/07/202317:01GLOBEAquestive Therapeutics to Report Second Quarter 2023..
25/07/202309:00GLOBEAquestive Therapeutics to Present Positive Topline Data from..
06/07/202309:00GLOBEAquestive Therapeutics to Present Positive Data from..
29/06/202309:42GLOBEAquestive Therapeutics Provides Business Update and..

Seu Histórico Recente

Delayed Upgrade Clock